Compare Repligen Corporation Common Stock (RGEN) vs Super Micro Computer Inc (SMCI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Repligen Corporation Common Stock vs Super Micro Computer Inc — how do they compare? Repligen Corporation Common Stock trades at $178.15 (market cap $11.31B), while Super Micro Computer Inc trades at $34.65 (market cap $23.51B). The key difference: Super Micro Computer Inc is far larger — about 2.1× Repligen Corporation Common Stock's market cap, and Repligen Corporation Common Stock is trading nearer its 52-week high, Super Micro Computer Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and Super Micro Computer Inc for 20 Days on average.
| RGEN | SMCI | |
|---|---|---|
Market Cap | $11.31B | $23.51B |
Volume | 1,216,919 | 33,064,278 |
Sector | Health | Technology |
52-Week High | $194.57 | $55.04 |
52-Week Low | $102.87 | $20.53 |
Typical Hold Time | 0 Days | 20 Days |
Enterprise Value | $11.20B | $28.97B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Super Micro Computer (SMCI) trades at $39.07, down 2.28% on the day, with a bullish technical signal overall. The stock shows strong fundamentals with a P/E of 10.98 and P/S of 0.64, alongside robust earnings beats in recent quarters. Revenue grew to $21.97 billion in 2025, with net income of $1.05 billion. Analyst consensus is a Buy rating with a $42.33 price target, though sentiment is mixed amid AI server market volatility.
SMCI presents a value opportunity with low valuation multiples and strong profitability metrics like 26.53% ROE. However, risks include competitive pressures in AI infrastructure and potential liquidity concerns flagged in news. The stock's upside is supported by earnings momentum and institutional interest, but investors should weigh execution risks against growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →About Super Micro Computer Inc
Super Micro Computer, Inc., commonly known as Supermicro, is a leading provider of high-performance and high-efficiency server technology and innovation. The company specializes in designing, manufacturing, and selling advanced server, storage, and networking solutions, primarily for data centers, cloud computing, artificial intelligence, and 5G/Edge computing markets. SMCI's modular architecture allows for the rapid delivery of customized and purpose-built solutions, making it a key player in the enterprise computing and specialized AI infrastructure space.
Read more on SMCI →
